$0.3837
-0.0163[-4.08%]
At close: Apr 24
$0.3837
0[0.00%]
PreMarket: 4:07PM EDT
Galmed Pharmaceuticals
(NASDAQ:GLMD)Galmed Pharmaceuticals Stock (NASDAQ:GLMD), Earnings Estimates, EPS, and Revenue
Galmed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 4
EPS
$-0.980
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Galmed Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/30/2024 | AM | GLMD | Q1 | -$1.09 | — | — | — | $0.00 | — | — | — | Get Alert |
| 04/04/2024 | PM | GLMD | Q4 | -$1.50 | -$0.32 | -$0.98 | -206.25% | $0.00 | — | $0.00 | — | Get Alert |
| 11/22/2023 | PM | GLMD | Q3 | -$3.15 | -$0.30 | -$0.24 | 20.00% | $0.00 | — | $0.00 | — | Get Alert |
| 08/09/2023 | PM | GLMD | Q2 | -$2.25 | -$0.34 | -$0.95 | -179.41% | $0.00 | — | $0.00 | — | Get Alert |
| 06/01/2023 | AM | GLMD | Q1 | -$3.60 | -$1.50 | -$1.09 | 27.33% | $0.00 | — | $0.00 | — | Get Alert |
| 03/29/2023 | PM | GLMD | Q4 | -$4.50 | -$2.10 | -$1.50 | 28.57% | $0.00 | — | $0.00 | — | Get Alert |
| 11/16/2022 | PM | GLMD | Q3 | -$4.65 | -$2.40 | -$3.15 | -31.25% | $0.00 | — | $0.00 | — | Get Alert |
| 08/04/2022 | AM | GLMD | Q2 | -$4.95 | -$3.60 | -$2.25 | 37.50% | $0.00 | — | $0.00 | — | Get Alert |
| 05/17/2022 | AM | GLMD | Q1 | -$5.70 | -$4.80 | -$3.60 | 25.00% | $0.00 | — | $0.00 | — | Get Alert |
| 05/02/2022 | AM | GLMD | Q4 | -$7.20 | -$4.50 | -$4.50 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
| 11/08/2021 | AM | GLMD | Q3 | -$4.80 | -$5.40 | -$4.65 | 13.89% | $0.00 | — | $0.00 | — | Get Alert |
| 08/05/2021 | AM | GLMD | Q2 | -$3.90 | -$5.70 | -$4.95 | 13.16% | $0.00 | — | $0.00 | — | Get Alert |
| 05/13/2021 | AM | GLMD | Q1 | -$4.35 | -$5.85 | -$5.70 | 2.56% | $0.00 | — | $0.00 | — | Get Alert |
| 03/18/2021 | AM | GLMD | Q4 | -$5.85 | -$5.40 | -$7.20 | -33.33% | $0.00 | — | $0.00 | — | Get Alert |
| 11/12/2020 | AM | GLMD | Q3 | -$3.15 | -$4.50 | -$4.80 | -6.67% | $0.00 | — | $0.00 | — | Get Alert |
| 08/06/2020 | AM | GLMD | Q2 | -$3.00 | -$0.32 | -$3.90 | -1118.75% | $0.00 | — | $0.00 | — | Get Alert |
| 05/14/2020 | AM | GLMD | Q1 | -$2.55 | -$5.55 | -$4.35 | 21.62% | $0.00 | — | $0.00 | — | Get Alert |
| 03/12/2020 | AM | GLMD | Q4 | -$2.70 | -$5.10 | -$5.85 | -14.71% | $0.00 | — | $0.00 | — | Get Alert |
| 11/06/2019 | AM | GLMD | Q3 | -$0.75 | -$4.35 | -$3.15 | 27.59% | $1.50M | — | $0.00 | — | Get Alert |
FAQ
When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?
Galmed Pharmaceuticals (GLMD) is scheduled to report earnings on May 30, 2024. The last reported earnings were for reported on April 4, 2024 for Q4.
What were the latest earnings per share (EPS) for Galmed Pharmaceuticals (NASDAQ:GLMD)?
The Actual EPS was $-0.98, which missed the estimate of $-0.32.
What were Galmed Pharmaceuticals’s (NASDAQ:GLMD) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.